The 10-second takeaway
For the quarter ended June 30 (Q2), Medidata Solutions beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. Non-GAAP earnings per share grew significantly. GAAP earnings per share increased significantly.
Margins increased across the board.
Medidata Solutions chalked up revenue of $68.1 million. The six analysts polled by S&P Capital IQ wanted to see sales of $66.7 million on the same basis. GAAP reported sales were 27% higher than the prior-year quarter's $53.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.36. The six earnings estimates compiled by S&P Capital IQ anticipated $0.29 per share. Non-GAAP EPS of $0.36 for Q2 were 57% higher than the prior-year quarter's $0.23 per share. GAAP EPS of $0.19 for Q2 were 36% higher than the prior-year quarter's $0.14 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 75.1%, 460 basis points better than the prior-year quarter. Operating margin was 13.0%, 240 basis points better than the prior-year quarter. Net margin was 7.5%, 80 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $70.2 million. On the bottom line, the average EPS estimate is $0.31.
Next year's average estimate for revenue is $274.3 million. The average EPS estimate is $1.30.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 58 members out of 67 rating the stock outperform, and nine members rating it underperform. Among 16 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 15 give Medidata Solutions a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Medidata Solutions is outperform, with an average price target of $74.71.
Is Medidata Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Medidata Solutions to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.